Epoch Biotech
Dover, US · Founded 2022 · Delaware LLC
Founders & leadership
MR
Michael R. AcetiDirector/Manager
Reported raises · per SEC filings
Form D private placements$1.1M disclosed across 3 rounds · 2023–2025
▶$300KraisedJan 2026 · 5 investors · Other TechnologyRule 506(b)
▶$300KraisedJan 2026 · 5 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Michael R. AcetiExecutive Officer, Director
- Offering amount
- $1.7M
- Amount sold
- $300K
- First sale
- May 2025
- Incorporated
- Limited Liability Company, Delaware, 2022
- Federal exemptions
- 06b
▶$40KraisedJul 2024 · 2 investors · Other TechnologyRule 506(b)
▶$40KraisedJul 2024 · 2 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Michael R. AcetiExecutive Officer, Director
- Offering amount
- $620K
- Amount sold
- $40K
- First sale
- Jul 2024
- Incorporated
- Limited Liability Company, Delaware, 2022
- Federal exemptions
- 06b
▶$720KraisedJul 2023 · 10 investors · BiotechnologyRule 506(b)
▶$720KraisedJul 2023 · 10 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Michael AcetiExecutive Officer, Director
- Offering amount
- $1.5M
- Amount sold
- $720K
- First sale
- Mar 2023
- Incorporated
- Limited Liability Company, Delaware, 2022
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- How much funding has Epoch Biotech raised?
- Epoch Biotech has disclosed $1.1M raised across 3 rounds.
- Where is Epoch Biotech headquartered?
- Epoch Biotech is headquartered in Dover, US.